No abstract available
MeSH terms
-
COVID-19*
-
Diabetes Mellitus* / drug therapy
-
Diabetes Mellitus* / epidemiology
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
-
Pandemics
-
SARS-CoV-2
Substances
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors